Toggle light / dark theme

Death, resurrection and digital immortality in an AI world

Were you unable to attend Transform 2022? Check out all of the summit sessions in our on-demand library now! Watch here.

I have been thinking about death lately. Not a lot — a little. Possibly because I recently had a month-long bout of Covid-19. And, I read a recent story about the passing of the actor Ed Asner, famous for his role as Lou Grant in “The Mary Tyler Moore Show.” More specifically, the story of his memorial service where mourners were invited to “talk” with Asner through an interactive display that featured video and audio that he recorded before he died. The experience was created by StoryFile, a company with the mission to make AI more human. According to the company, their proprietary technology and AI can match pre-recorded answers with future questions, allowing for a real-time yet asynchronous conversation.

In other words, it feels like a Zoom conversation with a living person.

Hui Li, PhD, Discovers Gene Responsible for Deadliest Brain Tumor Also Causes Childhood Cancer

Hui Li, PhD, a Department of Pathology researcher, along with his team discovered that a gene responsible for the deadliest type of brain tumor is also found to be responsible for two forms of childhood cancer. The new discovery may open the door to the first targeted treatments for two types of rhabdomyosarcoma, a cancer of the soft tissue that primarily strikes young children. Research also suggests the gene may play an important role in other cancers that form in muscle, fat, nerves and other connective tissues in both children and adults. Hui Li, PhD, and team published their findings in the scientific journal PNAS.

Christian Angermayer on longevity and biotech investment

Christian Angermayer, founder of talks longevity investment, optimism on SPAC deal and light at the end of the tunnel for the biotech market.
One of the speakers at October’s Rejuvenation Startup Summit in Berlin is the entrepreneur and investor, Christian Angermayer.

With more than $3 billion under management through his Apeiron Investment Group, Angermayer is a major figure in the longevity sector through his platform biotech companies Cambrian and Rejuveron – building on his belief that everyone wants to live healthier, happier and longer lives.

Ahead of Berlin’s meeting, our editor-in-chief caught up with Angermayer for a video interview in which he shares his views on subjects ranging from longevity investing, the biotech market, and what’s happening with his $200 million SPAC with David Sinclair and Peter Attia.

Visit Longevity. Technology — https://bit.ly/3PwtH8Y

Follow Longevity. Technology on:
Twitter — https://bit.ly/3AMIXuq.
Facebook — https://bit.ly/3z8H1v5
Instagram — https://bit.ly/3IDvVRX
Linkedin — https://bit.ly/3yIfDmf

Boosting Neuron Formation Restores Memory in Mice With Alzheimer’s Disease

Summary: Increasing neurogenesis by deleting the Bax gene in mouse models of Alzheimer’s improved the animals’ performance in tests measuring spatial recognition and contextual memory.

Source: Rockefeller University.

Researchers at the University of Illinois Chicago have discovered that increasing the production of new neurons in mice with Alzheimer’s disease (AD) rescues the animals’ memory defects.

New Method Enables Long-Lasting Imaging of Rapid Brain Activity in Individual Cells Deep in the Cortex

Summary: Researchers have developed a new sensor that allows scientists to image the brain without missing signals for an extended period of time and deeper in the brain than current technology allows.

Source: Baylor College of Medicine.

As you are reading these words, certain regions of your brain are displaying a flurry of millisecond-fast electrical activity. Visualizing and measuring this electrical activity is crucial to understand how the brain enables us to see, move, behave or read these words.

New Research Shows How Dopamine Plays a Key Role in Consciousness

The Brain Chemical Involved in Consciousness

So how do we help these people? The brain is more than just a congregation of different areas. Brain cells also rely on a number of chemicals to communicate with other cells, enabling a number of brain functions. Before our study, there was already some evidence that dopamine, well known for its role in reward, also plays a role in disorders of consciousness.

For example, one study showed that dopamine release in the brain is impaired in minimally conscious patients. Moreover, a number of small-scale studies have shown that patients’ consciousness can improve by giving them drugs that act through dopamine.

/* */